🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic material and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home.

Within minutes of joining one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these groups, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly serious health risks”.